Imaging in radiation oncology: A perspective

Oncologist

Volumn 15, Issue 4, 2010, Pages 338-349

  Dawson, Laura A ^a   Ménard, Cynthia ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Image guided radiation therapy; Imaging; Radiation oncology

Indexed keywords

ARTICLE; BRACHYTHERAPY; CANCER CELL; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; DIAGNOSTIC IMAGING; EXTERNAL BEAM RADIOTHERAPY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; INTERVENTIONAL RADIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RADIATION RESPONSE; RADIODIAGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE INJURY; TREATMENT PLANNING;

BRACHYTHERAPY; DECISION MAKING; DIAGNOSTIC IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASMS; PATIENT CARE PLANNING; POSITRON-EMISSION TOMOGRAPHY; RADIATION DOSAGE; RADIATION ONCOLOGY; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77951751337     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2009-S106     Document Type: Article

References (86)

1. Eisbruch A, Dawson LA, Kim HM et al. Conformal and intensity modulated irradiation of head and neck cancer: The potential for improved target irradiation, salivary gland function, and quality of life. Acta Otorhinolaryngol Belg 1999;53:271-275.
2. van Tinteren H, Hoekstra OS, Smit EF et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: The PLUS multicentre randomised trial. Lancet 2002;359:1388-1393.
3. Khoo VS, Joon DL. New developments in MRI for target volume delineation in radiotherapy. Br J Radiol 2006;79:S2-S15.
4. Haie-Meder C, Pötter R, Van Limbergen E et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005;74:235-245.
5. Krempien RC, Daeuber S, Hensley FW et al. Image fusion of CT and MRI data enables improved target volume definition in 3D-brachytherapy treatment planning. Brachytherapy 2003;2:164-171.
6. Voroney JP, Brock KK, Eccles C et al. Prospective comparison of computed tomography and magnetic resonance imaging for liver cancer delineation using deformable image registration. Int J Radiat Oncol Biol Phys 2006;66:780-791.
7. Emami B, Sethi A, Petruzzelli GJ. Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2003;57:481-488.
8. Brock KK, Dawson LA, Sharpe MB et al. Application of a novel deformable image registration technique to facilitate classification, tracking and targeting of tumor and normal tissue. Int J Radiat Oncol Biol Phys 2004; 60:S227.
9. Kashani R, Hub M, Balter JM et al. Objective assessment of deformable image registration in radiotherapy: A multi-institution study. Med Phys 2008;35:5944-5953.
10. Geets X, Daisne JF, Tomsej M et al. Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: Comparison between preand per-treatment studies. Radiother Oncol 2006;78:291-297.
11. Langen KM, Jones DT. Organ motion and its management. Int J Radiat Oncol Biol Phys 2001;50:265-278.
12. Case RB, Sonke JJ, Moseley D et al. Inter-and intra-fraction variability in liver position in non-breath-hold stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2009;75:302-308.
13. Velec M, Waldron J, O'Sullivan B et al. Cone beam CT assessment of interand intra-fraction setup error of two head and neck cancer thermoplastic masks. Int J Radiat Oncol Biol Phys 2009 (in press).
14. Dawson LA, Eccles C, Bissonnette JP et al. Accuracy of daily image guidance for hypofractionated liver radiotherapy with active breathing control. Int J Radiat Oncol Biol Phys 2005;62:1247-1252.
15. Balter JM, Brock KK, Litzenberg DW et al. Daily targeting of intrahepatic tumors for radiotherapy. Int J Radiat Oncol Biol Phys 2002;52:266-271.
16. Shirato H, Shimizu S, Kitamura K et al. Four-dimensional treatment planning and fluoroscopic real-time tumor tracking radiotherapy for moving tumor. Int J Radiat Oncol Biol Phys 2000;48:435-442.
17. Keall PJ, Joshi S, Vedam SS et al. Four-dimensional radiotherapy planning for DMLC-based respiratory motion tracking. Med Phys 2005;32:942-951.
18. Gerszten PC, Ozhasoglu C, Burton SA et al. Evaluation of CyberKnife frameless real-time image-guided stereotactic radiosurgery for spinal lesions. Stereotact Funct Neurosurg 2003;81:84-89.
19. Murphy MJ, Adler JR Jr, Bodduluri M et al. Image-guided radiosurgery for the spine and pancreas. Comput Aided Surg 2000;5:278-288.
20. Koong AC, Le QT, Ho A et al. Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2004;58:1017-1021.
21. Balter JM, Lam KL, Sandler HM et al. Automated localization of the prostate at the time of treatment using implanted radiopaque markers: Technical feasibility. Int J Radiat Oncol Biol Phys 1995;33:1281-1286.
22. Schallenkamp JM, Herman MG, Kruse JJ et al. Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging. Int J Radiat Oncol Biol Phys 2005;63:800-811.
23. Balter JM, Dawson LA, Kazanjian S et al. Determination of ventilatory liver movement via radiographic evaluation of diaphragm position. Int J Radiat Oncol Biol Phys 2001;51:267-270.
24. Wu J, Haycocks T, Alasti H et al. Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers. Radiother Oncol 2001;61:127-133.
25. Van den Heuvel F, Powell T, Seppi E et al. Independent verification of ultrasound based image-guided radiation treatment, using electronic portal imaging and implanted gold markers. Med Phys 2003;30:2878-2887.
26. Mohan DS, Kupelian PA, Willoughby TR. Short-course intensity-modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland. Int J Radiat Oncol Biol Phys 2000;46:575-580.
27. Kuban DA, Dong L, Cheung R et al. Ultrasound-based localization. Semin Radiat Oncol 2005;5:180-191.
28. Langen KM, Pouliot J, Anezinos C et al. Evaluation of ultrasound-based prostate localization for image-guided radiotherapy. Int J Radiat Oncol Biol Phys 2003;57:635-644.
29. Fuss M, Salter BJ, Herman TS et al. External beam radiation therapy for hepatocellular carcinoma: Potential of intensity-modulated and imageguided radiation therapy. Gastroenterology 2004;127(suppl 1):S206-S217.
30. Artignan X, Smitsmans MH, Lebesque JV et al. Online ultrasound image guidance for radiotherapy of prostate cancer: Impact of image acquisition on prostate displacement. Int J Radiat Oncol Biol Phys 2004;59:595-601.
31. Court L, Rosen I, Mohan R et al. Evaluation of mechanical precision and alignment uncertainties for an integrated CT/LINAC system. Med Phys 2003;30:1198-1210.
32. Kuriyama K, Onishi H, Sano N et al. A new irradiation unit constructed of self-moving gantry-CT and linac. Int J Radiat Oncol Biol Phys 2003;55: 428-435.
33. Onishi H, Kuriyama K, Komiyama T et al. A new irradiation system for lung cancer combining linear accelerator, computed tomography, patient self-breath-holding, and patient-directed beam-control without respiratory monitoring devices. Int J Radiat Oncol Biol Phys 2003;56:14-20.
34. Uematsu M, Fukui T, Shioda A et al. A dual computed tomography linear accelerator unit for stereotactic radiation therapy: A new approach without cranially fixated stereotactic frames. Int J Radiat Oncol Biol Phys 1996;35: 587-592.
35. Cheng CW, Wong J, Grimm L et al. Commissioning and clinical implementation of a sliding gantry CT scanner installed in an existing treatment room and early clinical experience for precise tumor localization. Am J Clin Oncol 2003;26:e28-e36.
36. Mackie TR, Kapatoes J, Ruchala K et al. Image guidance for precise conformal radiotherapy. Int J Radiat Oncol Biol Phys 2003;56:89-105.
37. Groh BA, Siewerdsen JH, Drake DG et al. A performance comparison of flat-panel imager-based MV and kV cone-beam CT. Med Phys 2002;29: 967-975.
38. Langen KM, Zhang Y, Andrews RD et al. Initial experience with megavoltage (MV) CT guidance for daily prostate alignments. Int J Radiat Oncol Biol Phys 2005;62:1517-1524.
39. Welsh JS, Bradley K, Ruchala KJ et al. Megavoltage computed tomography imaging: A potential tool to guide and improve the delivery of thoracic radiation therapy. Clin Lung Cancer 2004;5:303-306.
40. Langen KM, Meeks SL, Poole DO et al. The use of megavoltage CT (MVCT) images for dose recomputations. Phys Med Biol 2005;50:4259-4276.
41. Jaffray DA, Drake DG, Moreau M et al. A radiographic and tomographic imaging system integrated into a medical linear accelerator for localization of bone and soft-tissue targets. Int J Radiat Oncol Biol Phys 1999;45:773-789.
42. Oldham M, Létourneau D, Watt L et al. Cone-beam-CT guided radiation therapy: A model for on-line application. Radiother Oncol 2005;75:271-278.
43. Sonke JJ, Zijp L, Remeijer P et al. Respiratory correlated cone beam CT. Med Phys 2005;32:1176-1186.
44. Létourneau D, Martinez AA, Lockman D et al. Assessment of residual error for online cone-beam CT-guided treatment of prostate cancer patients. Int J Radiat Oncol Biol Phys 2005;62:1239-1246.
45. Jaffray DA. Emergent technologies for 3-dimensional image-guided radiation delivery. Semin Radiat Oncol 2005;15:208-216.
46. Godfrey DJ, Yin FF, Oldham M et al. Digital tomosynthesis with an onboard kilovoltage imaging device. Int J Radiat Oncol Biol Phys 2006;65: 8-15.
47. Henry AM, Stratford J, McCarthy C et al. X-ray volume imaging in bladder radiotherapy verification. Int J Radiat Oncol Biol Phys 2006;64:1174-1178.
48. McBain CA, Henry AM, Sykes J et al. X-ray volumetric imaging in image-guided radiotherapy: The new standard in on-treatment imaging. Int J Radiat Oncol Biol Phys 2006;64:625-634.
49. Oelfke U, Tcking T, Nill S et al. Linac-integrated kV-cone beam CT: Technical features and first applications. Med Dosim 2006;31:62-70.
50. Li T, Xing L, Munro P et al. Four-dimensional cone-beam computed tomography using an on-board imager. Med Phys 2006;33:3826-3833.
51. Kamino Y, Takayama K, Kokubo M et al. Development of a four-dimensional image-guided radiotherapy system with a gimbaled x-ray head. Int J Radiat Oncol Biol Phys 2006;66:271-278.
52. Raaymakers BW, Raaijmakers AJ, Kotte AN et al. Integrating a MRI scanner with a 6 MV radiotherapy accelerator: Dose deposition in a transverse magnetic field. Phys Med Biol 2004;49:4109-4118.
53. Yan D, Lockman D, Martinez A et al. Computed tomography guided management of interfractional patient variation. Semin Radiat Oncol 2005;15: 168-179.
54. Wu Q, Liang J, Yan D. Application of dose compensation in image-guided radiotherapy of prostate cancer. Phys Med Biol 2006;51:1405-1419.
55. Moffat BA, Chenevert TL, Lawrence TS et al. Functional diffusion map: A noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A 2005;102:5524-5529.
56. Millender LE, Aubin M, Pouliot J et al. Daily electronic portal imaging for morbidly obese men undergoing radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2004;59:6-10.
57. Ghilezan M, Yan D, Liang J et al. Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery. Int J Radiat Oncol Biol Phys 2004;60:1602-1610.
58. de Crevoisier R, Tucker SL, Dong L et al. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 2005;62:965-973.
59. Kupelian PA, Willoughby TR, Reddy CA et al. Impact of image guidance on outcomes after external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008;70:1146-1150.
60. Rubens DJ, Yu Y, Barnes AS et al. Image-guided brachytherapy for prostate cancer. Radiol Clin North Am 2006;44:735-748, viii-ix.
61. Acher PL, Morris SL, Popert RJ et al. Permanent prostate brachytherapy: A century of technical evolution. Prostate Cancer Prostatic Dis 2006;9:215-220.
62. Pasteau O, Degrais P. De l'emploi du radium dans les cancers de la prostate. J Urol (Paris) 1913;4:341-345.
63. Aronowitz JN. Benjamin Barringer: Originator of the transperineal prostate implant. Urology 2002;60:731-734.
64. Whitmore WF Jr, Hilaris B, Grabstald H. Retropubic implantation of iodine 125 in the treatment of prostatic cancer. Trans Am Assoc Genitourin Surg 1972;64:55-57.
65. Acher PL, Dasgupta P, Popert R. Improving prostate brachytherapy by developing image guidance. BJU Int 2007;99:241-243.
66. Holm HH, Juul N, Pedersen JF et al. Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. J Urol 1983;130:283-286.
67. Grimm PD, Blasko JC, Sylvester JE et al. 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy. Int J Radiat Oncol Biol Phys 2001;51:31-40.
68. Citrin D, Ning H, Guion P et al. Inverse treatment planning based on MRI for HDR prostate brachytherapy. Int J Radiat Oncol Biol Phys 2005;61: 1267-1275.
69. Fuller DB, Jin H, Koziol JA et al. CT-ultrasound fusion prostate brachytherapy: A dynamic dosimetry feedback and improvement method. A report of 54 consecutive cases. Brachytherapy 2005;4:207-216.
70. Kaplan ID, Meskell P, Oldenburg NE et al. Real-time computed tomography dosimetry during ultrasound-guided brachytherapy for prostate cancer. Brachytherapy 2006;5:147-151.
71. Mizowaki T, Cohen GN, Fung AY et al. Towards integrating functional imaging in the treatment of prostate cancer with radiation: The registration of the MR spectroscopy imaging to ultrasound/CT images and its implementation in treatment planning. Int J Radiat Oncol Biol Phys 2002;54: 1558-1564.
72. Pouliot J, Kim Y, Lessard E et al. Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging. Int J Radiat Oncol Biol Phys 2004;59:1196-1207.
73. Reed DR, Wallner KE, Narayanan S et al. Intraoperative fluoroscopic dose assessment in prostate brachytherapy patients. Int J Radiat Oncol Biol Phys 2005;63:301-307.
74. Reynier C, Troccaz J, Fourneret P et al. MRI/TRUS data fusion for prostate brachytherapy. Preliminary results. Med Phys 2004;31:1568-1575.
75. DiBiase SJ, Hosseinzadeh K, Gullapalli RP et al. Magnetic resonance spectroscopic imaging-guided brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2002;52:429-438.
76. D'Amico AV, Cormack R, Tempany CM et al. Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 1998;42:507-515.
77. D'Amico AV, Moul JW, Carroll PR et al. Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Natl Cancer Inst 2003;95:1376-1383.
78. Zelefsky MJ, Yamada Y, Cohen GN et al. Intraoperative real-time planned conformal prostate brachytherapy: Post-implantation dosimetric outcome and clinical implications. Radiother Oncol 2007;84:185-189.
79. Dubois DF, Prestidge BR, Hotchkiss LA et al. Intraobserver and interobserver variability of MR imaging-and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy. Radiology 1998;207:785-789.
80. Crook J, Milosevic M, Catton P et al. Interobserver variation in postimplant computed tomography contouring affects quality assessment of prostate brachytherapy. Brachytherapy 2002;1:66-73.
81. Bice WS Jr, Prestidge BR, Grimm PD et al. Centralized multiinstitutional postimplant analysis for interstitial prostate brachytherapy. Int J Radiat Oncol Biol Phys 1998;41:921-927.
82. DiBiase SJ, Wallner K, Tralins K et al. Brachytherapy radiation doses to the neurovascular bundles. Int J Radiat Oncol Biol Phys 2000;46:1301-1307.
83. Crook JM, Potters L, Stock RG et al. Critical organ dosimetry in permanent seed prostate brachytherapy: Defining the organs at risk. Brachytherapy 2005;4:186-194.
84. Bentzen SM. Theragnostic imaging for radiation oncology: Dose-painting by numbers. Lancet Oncol 2005;6:112-117.
85. Chao KS, Bosch WR, Mutic S et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2001;49:1171-1182.
86. Sullivan DC. Imaging as a quantitative science. Radiology 2008; 248:328-332.